Novel Coronavirus (COVID-19) Statement
ACIs are free for healthcare professionals in the clinical setting, students and patient advocates.
Upon completion of this activity, participants should be able to:
Full accreditation information may be found by clicking on each activity's link above.
The online courses listed below are free CME-, CPE-, CNE- and MOC-certified pre-program courses for the ACI regional education series. Participation by ACI program attendees is strongly recommended, however the courses are available to anyone free of charge.
Basic Immunology ConceptsThis course covers some of the key immunology needed to understand the ACI program. Basic Immunology Concepts is also the first module in the Certificate in Cancer Immunotherapy program, produced by SITC. ACI registrants will receive a discount code to use when registering for the Basic Immunology Concepts course.
Mechanisms of Immune-related Adverse Events
This interactive course provides an overview of the mechanisms by which cancer immunotherapy may activate immune-related adverse events (irAEs). The foundational knowledge presented in this course is critical to understanding how and why immune-related adverse events occur and how they can be treated.
The 2021-2022 Advances in Cancer Immunotherapy™ series is brought to you in collaboration with the Association of Community Cancer Centers, Advanced Practitioner Society for Hematology and Oncology, and the Hematology/Oncology Pharmacy Association.
ACI Registration Info
Technology Information and Policy
ACI Online Programs
ACI Enduring Materials
The ACI series is jointly provided by Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer.
The 2021–2022 Advances in Cancer Immunotherapy™ educational series is supported, in part, by independent medical education grants from AstraZeneca Pharmaceuticals LP, Bristol Myers Squibb, Exelixis, Inc., Genentech, a Member of the Roche Group, Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc. (MSD), Novartis Pharmaceuticals Corporation, and Regeneron Pharmaceuticals Inc. (as of 10/13/2021)
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com